Extracted from this filing and checked against the source text.
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.98
Launch One Acquisition Corp. terminated Business Combination Agreement with Minovia Therapeutics Ltd. valued at Termination and Release Agreement entered into on January 30, 2026 mutually terminating the Business (effective 2026-01-30).
- Action
- termination
- Agreement
- merger
- Counterparty
- Minovia Therapeutics Ltd.
- Value
- Termination and Release Agreement entered into on January 30, 2026 mutually terminating the Business
- Effective
- 2026-01-30
Exact text from the filing
Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed, Launch One Acquisition Corp. (the “ Company ”) entered into a Business Combination Agreement, dated as of June 25, 2025, as amended on August 12, 2025, September 4, 2025, September 26, 2025 and January 6, 2026 (collectively, the “ BCA ”) with (i) Launch One Sponsor LLC, a Delaware limited liability company, in the capacity as the SPAC Representative (as defined in the BCA) under the BCA (the “ SPAC Representative ”), (ii) Minovia Therapeutics Ltd., an Israeli company limited by shares (“ Minovia ”), (iii) Natalie Yivgi-Ohana, in the capacity as the Seller Representative (as defined in the BCA) under the BCA (the “ Seller Representative ”), (iv) Mito US One Ltd., an Israeli company limited by shares (“ Pubco ”), and (v) Mito Sub Israel Ltd., an Israeli company limited by shares and a wholly-owned subsidiary of Pubco (“ Company Merger Sub ”).
View on SEC.gov